Abstract
To evaluate the association of plasma osteoprotegerin (OPG) to hospitalisation for ischaemic heart disease (IHD), ischaemic stroke and all-cause mortality, and the effect of combining plasma OPG and high-sensitivity C-reactive protein (hsCRP).
Original language | English |
---|---|
Journal | Heart |
Volume | 99 |
Issue number | 2 |
Pages (from-to) | 106-10 |
Number of pages | 5 |
ISSN | 1355-6037 |
DOIs | |
Publication status | Published - 2013 |